Xenon Pharmaceuticals XENE
$ 40.2
2.19%
Quarterly report 2024-Q3
added 11-12-2024
Xenon Pharmaceuticals Balance Sheet 2011-2024 | XENE
Annual Balance Sheet Xenon Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-138 M | -46.8 M | -167 M | - | -9.22 M | -52.7 M | -13.7 M | -17.1 M | -58.7 M | -72 M | -38 M | -58.5 M | - |
Long Term Debt |
9.6 M | 9.95 M | 7.65 M | - | 10.9 M | 15 M | 6.1 M | - | - | - | - | 1.66 M | - |
Long Term Debt Current |
1.3 M | 488 K | 605 K | 265 K | 168 K | - | 700 K | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 12.3 M | 15 M | 6.1 M | 70 K | 133 K | 353 K | 12.2 M | 31.5 M | - |
Total Current Liabilities |
27.3 M | 22.7 M | 14.3 M | 14.8 M | 43.4 M | 4.12 M | 4.08 M | 3.52 M | 2.78 M | 14.3 M | - | - | - |
Total Liabilities |
36.9 M | 32.6 M | 22 M | 17.8 M | 55.7 M | 19.1 M | 10.2 M | 3.59 M | 2.92 M | 14.6 M | 30.4 M | 50.7 M | - |
Deferred Revenue |
- | - | - | - | 29.7 M | - | - | - | 157 K | 11.6 M | 15.9 M | 17 M | - |
Retained Earnings |
-665 M | -483 M | -357 M | -278 M | -250 M | -208 M | -173 M | -143 M | -120 M | -104 M | -117 M | -129 M | - |
Total Assets |
965 M | 754 M | 572 M | 189 M | 148 M | 122 M | 46.1 M | 67.5 M | 63.9 M | 87.4 M | 54.5 M | 63.3 M | - |
Cash and Cash Equivalents |
149 M | 57.2 M | 176 M | 45 M | 24.8 M | 67.8 M | 20.5 M | 17.1 M | 58.7 M | 72 M | 38 M | 60.2 M | - |
Book Value |
928 M | 721 M | 550 M | 171 M | 92 M | 103 M | 35.9 M | 63.9 M | 61 M | 72.8 M | 24.1 M | 12.6 M | - |
Total Shareholders Equity |
928 M | 721 M | 550 M | 171 M | 92 M | 103 M | 35.9 M | 63.9 M | 61 M | 72.8 M | -78.4 M | -89.9 M | - |
All numbers in USD currency
Quarterly Balance Sheet Xenon Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
8.4 M | 8.68 M | 9.1 M | 9.6 M | 9.76 M | 10.3 M | 10.4 M | 9.95 M | 7.16 M | 7.85 M | 8.22 M | 7.65 M | 2.56 M | 2.75 M | 2.9 M | 3.05 M | 3.05 M | 3.05 M | 3.05 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 15 M | 15 M | 15 M | 15 M | 6.1 M | 6.1 M | 6.1 M | 6.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
38.1 M | 40 M | 31.3 M | 36.9 M | 34.5 M | 38.4 M | 32.9 M | 32.6 M | 22.7 M | 21.6 M | 16.2 M | 22 M | 15.4 M | 17.7 M | 14.4 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 55.7 M | 55.7 M | 55.7 M | 55.7 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 3.59 M | 3.59 M | 3.59 M | 3.59 M | 2.92 M | 2.92 M | 2.92 M | 2.92 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 30.4 M | 30.4 M | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | 2.2 M | 3.02 M | 3.64 M | 3.64 M | 3.64 M | 3.64 M | 3.64 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | - | - | - | - | - | - | - | - | - | - | - | - | 157 K | 157 K | 157 K | 157 K | 11.6 M | 11.6 M | 11.6 M | 11.6 M | 15.9 M | 15.9 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-834 M | -771 M | -713 M | -665 M | -620 M | -572 M | -524 M | -483 M | -445 M | -408 M | -377 M | -357 M | -332 M | -316 M | -294 M | -278 M | -278 M | -278 M | -278 M | -250 M | -250 M | -250 M | -250 M | -208 M | -208 M | -208 M | -208 M | -173 M | -173 M | -173 M | -173 M | -143 M | -143 M | -143 M | -143 M | -120 M | -120 M | -120 M | -120 M | -104 M | -104 M | -104 M | -104 M | -117 M | -117 M | - | - | - | - | - | - | - | - | - | - |
Total Assets |
836 M | 884 M | 919 M | 965 M | 671 M | 685 M | 720 M | 754 M | 776 M | 807 M | 558 M | 572 M | 264 M | 275 M | 291 M | 189 M | 189 M | 189 M | 189 M | 148 M | 148 M | 148 M | 148 M | 122 M | 122 M | 122 M | 122 M | 46.1 M | 46.1 M | 46.1 M | 46.1 M | 67.5 M | 67.5 M | 67.5 M | 67.5 M | 63.9 M | 63.9 M | 63.9 M | 63.9 M | 87.4 M | 87.4 M | 87.4 M | 87.4 M | 54.5 M | 54.5 M | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
87.6 M | 137 M | 58.9 M | 149 M | 99.6 M | 64.6 M | 69.5 M | 57.2 M | 103 M | 370 M | 117 M | 176 M | 87.8 M | 82.9 M | 88 M | 45 M | 45 M | 45 M | 45 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 67.8 M | 67.8 M | 67.8 M | 67.8 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 58.7 M | 58.7 M | 58.7 M | 58.7 M | 72 M | 72 M | 72 M | 72 M | 38 M | 38 M | - | - | 60.2 M | - | - | - | 13.9 M | - | - | - |
Book Value |
798 M | 844 M | 888 M | 928 M | 637 M | 646 M | 687 M | 721 M | 753 M | 786 M | 542 M | 550 M | 249 M | 257 M | 276 M | 171 M | 171 M | 171 M | 171 M | 92 M | 92 M | 92 M | 92 M | 103 M | 103 M | 103 M | 103 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 63.9 M | 63.9 M | 63.9 M | 63.9 M | 61 M | 61 M | 61 M | 61 M | 72.8 M | 72.8 M | 72.8 M | 72.8 M | 24.1 M | 24.1 M | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
798 M | 844 M | 888 M | 928 M | 637 M | 646 M | 687 M | 721 M | 753 M | 786 M | 542 M | 550 M | 249 M | 257 M | 276 M | 171 M | 171 M | 171 M | 171 M | 92 M | 92 M | 92 M | 92 M | 103 M | 103 M | 103 M | 103 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 63.9 M | 63.9 M | 63.9 M | 63.9 M | 61 M | 61 M | 61 M | 61 M | 72.8 M | 72.8 M | 72.8 M | 72.8 M | -78.4 M | -78.4 M | - | - | -89.9 M | - | - | - | -86.3 M | - | - | - |
All numbers in USD currency